BACKGROUND: Cerebrovascular ischemic stroke is highly prevalent in the general population and is considered one of the frequent causes of mortality and disability. Insulin-like growth factor-1 (IGF-1) is recognized as an important neuro-protective factor against cerebral vascular ischemic insult. AIM OF THE WORK: To study the relationship between serum IGF-1 levels and acute ischemic stroke (AIS) in the Egyptian population. PATIENTS AND METHODS: Two hundred patients with AIS (within the first 24 h) were subjected to full neurological examination, assessment of stroke severity using National Institute of Health Stroke Scale (NIHSS) and measurement of serum IGF-1 levels. The control group included 100 subjects matched for age, gender, and conventional vascular risk factors. RESULTS: Serum IGF-1 levels were significantly reduced in cases of first AIS compared to control group. A reduced serum IGF-1 level was an independent risk factor for ischemic stroke with cut off value less than 148.3 ng/ml associated with increased AIS risk. CONCLUSION: Lower IGF-1 levels are significantly related to risk of ischemic stroke occurrence, independent from other conventional risk factors in the Egyptian population.
BACKGROUND: Cerebrovascular ischemic stroke is highly prevalent in the general population and is considered one of the frequent causes of mortality and disability. Insulin-like growth factor-1 (IGF-1) is recognized as an important neuro-protective factor against cerebral vascular ischemic insult. AIM OF THE WORK: To study the relationship between serum IGF-1 levels and acute ischemic stroke (AIS) in the Egyptian population. PATIENTS AND METHODS: Two hundred patients with AIS (within the first 24 h) were subjected to full neurological examination, assessment of stroke severity using National Institute of Health Stroke Scale (NIHSS) and measurement of serum IGF-1 levels. The control group included 100 subjects matched for age, gender, and conventional vascular risk factors. RESULTS: Serum IGF-1 levels were significantly reduced in cases of first AIS compared to control group. A reduced serum IGF-1 level was an independent risk factor for ischemic stroke with cut off value less than 148.3 ng/ml associated with increased AIS risk. CONCLUSION: Lower IGF-1 levels are significantly related to risk of ischemic stroke occurrence, independent from other conventional risk factors in the Egyptian population.
Authors: V Tillmann; L Patel; M S Gill; A J Whatmore; D A Price; M S Kibirige; J K Wales; P E Clayton Journal: Clin Endocrinol (Oxf) Date: 2000-09 Impact factor: 3.478
Authors: Randolph Hutter; Bernhard V Sauter; Ernane D Reis; Merce Roque; David Vorchheimer; Francine E Carrick; John T Fallon; Valentin Fuster; Juan J Badimon Journal: Circulation Date: 2003-03-17 Impact factor: 29.690
Authors: Robert C Kaplan; Aileen P McGinn; Michael N Pollak; Lewis H Kuller; Howard D Strickler; Tom E Rohan; Anne R Cappola; XiaoNan Xue; Bruce M Psaty Journal: J Clin Endocrinol Metab Date: 2007-01-30 Impact factor: 5.958
Authors: Maria Luisa Granada; Angels Ulied; Felipe F Casanueva; Antonio Pico; Tomas Lucas; Elena Torres; Anna Sanmartí Journal: Clin Endocrinol (Oxf) Date: 2007-11-02 Impact factor: 3.478
Authors: Ronenn Roubenoff; Helen Parise; Hélène A Payette; Leslie W Abad; Ralph D'Agostino; Paul F Jacques; Peter W F Wilson; Charles A Dinarello; Tamara B Harris Journal: Am J Med Date: 2003-10-15 Impact factor: 4.965
Authors: Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong Journal: Circulation Date: 2007-12-17 Impact factor: 29.690